Topics

High-grade gliomas | Treatment | Clinical trials | Sitagliptin

Home > Publications > Topics > High-grade gliomas > Treatment > Clinical trials > Sitagliptin

Qureshi M, Peereboom D, Zabor E, Angelov L, Barnett G, Dhawan A, Grabowski M, Hufsey R, Lobbous M, Malkin M, Lucas A, Mohammadi A, Soni P, Stevens G, Torres-Trejo A, Lathia J.
TIP26-314: Targeting Macrophage Migration Inhibitory Factor: A Phase 2 and Pharmacodynamic Study of Sitagliptin in Patients With Progressive Grade 4 Gliomas.
J Natl Compr Canc Netw. 2026 Mar 31;24(3.5):TIP26-314. doi: 10.6004/jnccn.2025.7219. PMID: 42066799. Trial registration ID: Unidentified˰ ˍ